RT Journal Article
SR Electronic
T1 ANALYZING THE PATTERN OF USE OF ANTIBIOTICS IN A GHANAIAN DISTRICT HOSPITAL, ACROSS TWO DIFFERENT YEARS, USING THE WHO AWARE CLASSIFICATION
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.27.23297681
DO 10.1101/2023.10.27.23297681
A1 Opoku-Agyeman, Kwame
A1 Forson, David
A1 Acheampong, Gerald Anim
A1 Addo, Daniel
A1 Akwasi, Thomas Afrifa
A1 Asamoah, Yaw Asiamah
A1 Prince, Ayim Britwum
A1 Baffour, Adade-Boateng Kyei
A1 Frimpong, Prince Boakye
YR 2023
UL http://medrxiv.org/content/early/2023/10/28/2023.10.27.23297681.abstract
AB Background There has been an increment in the resistance of microorganisms to various antibiotics used in regional hospitals in the Ashanti region of Ghana and the country. This has led to difficulty in selecting agents to treat patients without the associated increment in side effects, the astronomical increase in the cost of medical care and a longer duration of hospitalization. In this study, we analyze the pattern of antibiotic use in a district hospital using the WHO AWaRe recommendation.Objectives To ascertain the general pattern of antibiotic use with reference to the Access, Watch and Reserve Classes using the selected parameters (year of visit and patient demographics) and to confirm if the standard set by the WHO with respect to Access Class antibiotics is met.Method Files of patients, in 2021 and 2022, were systematically sampled from the database of SDA Hospital - Kwadaso (the hospital involved), and data concerning the visits for which antibiotics were administered were extracted to carry out the analysis required. The data extracted included the year of visit, demographics of the patients involved (patient status, age and sex) and the antibiotics that were administered.Results This study seeks to ascertain the distribution of antibiotics used across the two years in the hospital of interest using the 2021 WHO AWaRe (Access, Watch and Reserve Antibiotics) Classification. Ultimately, the value, in percentage, of the distribution of the antibiotics used in the Access class will be compared to the target of at least 60% of the total antibiotic consumption being Access group antibiotics as recommended by WHO.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of Seventh-day Adventist Hospital, Kwadaso-Ghana gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.AMRAntimicrobial ResistanceAWaReAccess Watch and Reserve Classes of AntibioticsWHOWorld Health Organization